A graduate of Yale University School of Medicine, Dr. Nduka Amankulor completed his residency in neurosurgery at Yale New Haven Hospital. He then completed a postdoctoral fellowship in cancer and genetics biology, as well as a fellowship in neurosurgical oncology, at Memorial Sloan-Kettering Cancer Center in New York. Most recently, Dr. Amankulor served as Director of Neurosurgical Oncology at the University of Pittsburgh School of Medicine.
Dr. Amankulor's clinical practice focuses on primary and metastatic brain tumors, as well as spine, intraventricular and skull base tumors, and hydrocephalus. He uses the latest research and treatment options, such as Neuroendoport® surgery and fluorescence-based surgeries, to provide personalized treatment that creates optimal outcomes.
In addition to his clinical practice, Dr. Amankulor is a leading cancer immunobiologist whose laboratory has performed groundbreaking studies on mechanisms of immune dysfunction in glioblastoma, the most aggressive form of brain cancer. His research has been supported by the National Institutes of Health.
Board certified in neurosurgery, Dr. Amankulor sees patients at the Perelman Center for Advanced Medicine.